{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:26Z","timestamp":1792785866299,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"EU\/EFPIA Innovative Medicines Initiative 2 Joint","doi-asserted-by":"publisher","award":["116074"],"award-info":[{"award-number":["116074"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018722","name":"Jaap Schouten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018722","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noordwest Academie"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Risk assessment tools are needed for timely identification of patients with heart failure (HF) with reduced ejection fraction (HFrEF) who are at high risk of adverse events. In this study, we aim to derive a small set out of 4210 repeatedly measured proteins, which, along with clinical characteristics and established biomarkers, carry optimal prognostic capacity for adverse events, in patients with HFrEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In 382 patients, we performed repeated blood sampling (median follow-up: 2.1 years) and applied an aptamer-based multiplex proteomic approach. We used machine learning to select the optimal set of predictors for the primary endpoint (PEP: composite of cardiovascular death, heart transplantation, left ventricular assist device implantation, and HF hospitalization). The association between repeated measures of selected proteins and PEP was investigated by multivariable joint models. Internal validation (cross-validated c-index) and external validation (Henry Ford HF PharmacoGenomic Registry cohort) were performed. Nine proteins were selected in addition to the MAGGIC risk score, N-terminal pro-hormone B-type natriuretic peptide, and troponin T: suppression of tumourigenicity 2, tryptophanyl-tRNA synthetase cytoplasmic, histone H2A Type 3, angiotensinogen, deltex-1, thrombospondin-4, ADAMTS-like protein 2, anthrax toxin receptor 1, and cathepsin D. N-terminal pro-hormone B-type natriuretic peptide and angiotensinogen showed the strongest associations [hazard ratio (95% confidence interval): 1.96 (1.17\u20133.40) and 0.66 (0.49\u20130.88), respectively]. The multivariable model yielded a c-index of 0.85 upon internal validation and c-indices up to 0.80 upon external validation. The c-index was higher than that of a model containing established risk factors (P = 0.021).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Nine serially measured proteins captured the most essential prognostic information for the occurrence of adverse events in patients with HFrEF, and provided incremental value for HF prognostication beyond established risk factors. These proteins could be used for dynamic, individual risk assessment in a prospective setting. These findings also illustrate the potential value of relatively \u2018novel\u2019 biomarkers for prognostication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01851538?term=nCT01851538&amp;draw=2&amp;rank=1 24<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjdh\/ztad056","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T11:47:46Z","timestamp":1696333666000},"page":"444-454","source":"Crossref","is-referenced-by-count":20,"title":["Machine learning\u2013based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure"],"prefix":"10.1093","volume":"4","author":[{"given":"Marie","family":"de Bakker","sequence":"first","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun B","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"},{"name":"Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja J","family":"Rueten-Budde","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Martijn","family":"Akkerhuis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A","family":"Umans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Northwest Clinics , Wilhelminalaan 12, 1815 JD, Alkmaar , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J","family":"Brugts","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd","family":"Germans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Northwest Clinics , Wilhelminalaan 12, 1815 JD, Alkmaar , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-1562","authenticated-orcid":false,"given":"Marcel J T","family":"Reinders","sequence":"additional","affiliation":[{"name":"Delft Bioinformatics Lab, Delft University of Technology , Van Mourik Broekmanweg 6, 2628 XE, Delft , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D","family":"Katsikis","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"van der Spek","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ostroff","sequence":"additional","affiliation":[{"name":"SomaLogic, Inc. , 2945 Wilderness Pl., Boulder, CO 80301 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruicong","family":"She","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Henry Ford Health System , 1 Ford Pl, Detroit, MI 48202 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-1483","authenticated-orcid":false,"given":"David","family":"Lanfear","sequence":"additional","affiliation":[{"name":"Center for Individualized and Genomic Medicine Research (CIGMA), Henry Ford Hospital , 2799 W. Grand Boulevard, Detroit MI, 48202 , USA"},{"name":"Heart and Vascular Institute, Henry Ford Hospital , 2799 W. Grand Boulevard, Detroit, MI 48202 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert W","family":"Asselbergs","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Centers, Department of Cardiology, University of Amsterdam , Meibergdreef 9, 1105 AZ, Amsterdam , The Netherlands"},{"name":"Health Data Research UK and Institute of Health Informatics, University College London , Gower St, London, WC1E 6BT , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2559-7128","authenticated-orcid":false,"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9397-0900","authenticated-orcid":false,"given":"Dimitris","family":"Rizopoulos","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"},{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-9745","authenticated-orcid":false,"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Dr. Molenwaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"2023120106074903800_ztad056-B1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2023120106074903800_ztad056-B2","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023120106074903800_ztad056-B3","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"},{"key":"2023120106074903800_ztad056-B4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/CIRCULATIONAHA.116.025446","article-title":"Emerging affinity-based proteomic technologies for large-scale plasma profiling in cardiovascular disease","volume":"135","author":"Smith","year":"2017","journal-title":"Circulation"},{"key":"2023120106074903800_ztad056-B5","doi-asserted-by":"crossref","first-page":"19202","DOI":"10.1038\/s41598-019-55727-1","article-title":"Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction","volume":"9","author":"Cuvelliez","year":"2019","journal-title":"Sci Rep"},{"key":"2023120106074903800_ztad056-B6","doi-asserted-by":"crossref","first-page":"e003140","DOI":"10.1161\/CIRCGEN.120.003140","article-title":"Plasma proteomic profile predicts survival in heart failure with reduced ejection fraction","volume":"14","author":"Gui","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2023120106074903800_ztad056-B7","doi-asserted-by":"crossref","first-page":"eabj9625","DOI":"10.1126\/scitranslmed.abj9625","article-title":"A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk","volume":"14","author":"Williams","year":"2022","journal-title":"Sci Transl Med"},{"key":"2023120106074903800_ztad056-B8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/HCG.0000000000000058","article-title":"Heart failure in the era of precision medicine: a scientific statement from the American Heart Association","volume":"12","author":"Cresci","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2023120106074903800_ztad056-B9","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ejhf.2607","article-title":"Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR\u2013preserved trial","volume":"24","author":"Pocock","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2023120106074903800_ztad056-B10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ahj.2017.10.008","article-title":"Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study","volume":"196","author":"van Boven","year":"2018","journal-title":"Am Heart J"},{"key":"2023120106074903800_ztad056-B11","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"2023120106074903800_ztad056-B12","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"2023120106074903800_ztad056-B13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.kint.2017.09.013","article-title":"Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study","volume":"93","author":"Brankovic","year":"2018","journal-title":"Kidney Int"},{"key":"2023120106074903800_ztad056-B14","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"2023120106074903800_ztad056-B15","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-018-26640-w","article-title":"Stability and reproducibility of proteomic profiles measured with an aptamer-based platform","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"2023120106074903800_ztad056-B16","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci Rep"},{"key":"2023120106074903800_ztad056-B17","doi-asserted-by":"crossref","first-page":"e007956","DOI":"10.1161\/JAHA.117.007956","article-title":"Race and beta-blocker survival benefit in patients with heart failure: an investigation of self-reported race and proportion of African genetic ancestry","volume":"7","author":"Luzum","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2023120106074903800_ztad056-B18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"2023120106074903800_ztad056-B19","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1177\/2047487320922639","article-title":"Personalized screening intervals for measurement of N-terminal pro-B-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure","volume":"28","author":"Schuurman","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2023120106074903800_ztad056-B20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/sim.5727","article-title":"Testing for improvement in prediction model performance","volume":"32","author":"Pepe","year":"2013","journal-title":"Stat Med"},{"key":"2023120106074903800_ztad056-B21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jchf.2013.11.007","article-title":"Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis","volume":"2","author":"Savarese","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2023120106074903800_ztad056-B22","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jacc.2018.08.2165","article-title":"sST2 predicts outcome in chronic heart failure beyond NT-proBNP and high-sensitivity troponin T","volume":"72","author":"Emdin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023120106074903800_ztad056-B23","doi-asserted-by":"crossref","first-page":"e009555","DOI":"10.1161\/JAHA.118.009555","article-title":"Temporal patterns of 14 blood biomarker candidates of cardiac remodeling in relation to prognosis of patients with chronic heart failure-the Bio-SHiFT study","volume":"8","author":"Bouwens","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2023120106074903800_ztad056-B24","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/ejhf.1674","article-title":"The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach","volume":"22","author":"Hoes","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2023120106074903800_ztad056-B25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/1470320312465455","article-title":"The M235T polymorphism in the angiotensinogen gene and heart failure: a meta-analysis","volume":"15","author":"Chen","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2023120106074903800_ztad056-B26","first-page":"222","article-title":"M235t polymorphism in the angiotensinogen gene and cardiovascular disease: an updated meta-analysis of 39 case-control comparisons","volume":"21","author":"Zhai","year":"2019","journal-title":"Anatol J Cardiol"},{"key":"2023120106074903800_ztad056-B27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.96.1.220","article-title":"Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts","volume":"96","author":"Danser","year":"1997","journal-title":"Circulation"},{"key":"2023120106074903800_ztad056-B28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/eurheartj\/ehp012","article-title":"The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin\u2013angiotensin\u2013aldosterone system: therapeutic consequences?","volume":"30","author":"Klotz","year":"2009","journal-title":"Eur Heart J"},{"key":"2023120106074903800_ztad056-B29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(91)90501-N","article-title":"Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements","volume":"90","author":"Arnal","year":"1991","journal-title":"Am J Med"},{"key":"2023120106074903800_ztad056-B30","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.3390\/ijms20133182","article-title":"Renin activity in heart failure with reduced systolic function-new insights","volume":"20","author":"Sullivan","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023120106074903800_ztad056-B31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00380-010-0032-1","article-title":"Effect of mini-tyrosyl-tRNA synthetase\/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells","volume":"26","author":"Zeng","year":"2011","journal-title":"Heart Vessels"},{"key":"2023120106074903800_ztad056-B32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.omtn.2021.06.003","article-title":"The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease","volume":"25","author":"Zou","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"2023120106074903800_ztad056-B33","doi-asserted-by":"crossref","first-page":"14903","DOI":"10.1073\/pnas.2436330100","article-title":"Biologically active fragment of a human tRNA synthetase inhibits fluid shear stress-activated responses of endothelial cells","volume":"100","author":"Tzima","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023120106074903800_ztad056-B34","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1096\/fj.11-190728","article-title":"Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload","volume":"26","author":"Frolova","year":"2012","journal-title":"FASEB J"},{"key":"2023120106074903800_ztad056-B35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/ijms18071540","article-title":"Thrombospondins: a role in cardiovascular disease","volume":"18","author":"Chistiakov","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2023120106074903800_ztad056-B36","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1160\/TH11-03-0206","article-title":"Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels","volume":"106","author":"Corsetti","year":"2011","journal-title":"Thromb Haemost"},{"key":"2023120106074903800_ztad056-B37","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1038\/s41598-021-99032-2","article-title":"The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGF\u03b2 signalling in cardiac fibroblasts","volume":"11","author":"Rypdal","year":"2021","journal-title":"Sci Rep"},{"key":"2023120106074903800_ztad056-B38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.matbio.2014.12.002","article-title":"Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis","volume":"42","author":"Besschetnova","year":"2015","journal-title":"Matrix Biol"},{"key":"2023120106074903800_ztad056-B39","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s00018-018-2857-1","article-title":"Histones and heart failure in diabetes","volume":"75","author":"Yerra","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"2023120106074903800_ztad056-B40","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1038\/s41467-019-13306-y","article-title":"Profiling of the plasma proteome across different stages of human heart failure","volume":"10","author":"Egerstedt","year":"2019","journal-title":"Nat Commun"},{"key":"2023120106074903800_ztad056-B41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2013.11.008","article-title":"The role of ubiquitin ligases in cardiac disease","volume":"71","author":"Willis","year":"2014","journal-title":"J Mol Cell Cardiol"}],"container-title":["European Heart Journal - Digital Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjdh\/advance-article-pdf\/doi\/10.1093\/ehjdh\/ztad056\/52219857\/ztad056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjdh\/article-pdf\/4\/6\/444\/53897366\/ztad056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjdh\/article-pdf\/4\/6\/444\/53897366\/ztad056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T01:09:07Z","timestamp":1701392947000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjdh\/article\/4\/6\/444\/7289157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10,4]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjdh\/ztad056","relation":{},"ISSN":["2634-3916"],"issn-type":[{"value":"2634-3916","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,10,4]]}}}